Search Login Register

ramosetron (Nasea) Summary

Description: structure given in first source

Also Known As: Nasea; 5-((1-methyl-3-indolyl)carbonyl)-4,5,6,7-tetrahydro-1H-benzimidazol; Methanone, (1-methyl-1H-indol-3-yl)(4,5,6,7-tetrahydro-1H-benzimidazol-5-yl)-, monohydrochloride, (R)-; YM 060; YM-060 Show All >>

Networked: 162 relevant articles (77 outcomes, 72 trials/studies) for this Bio-Agent

Key Diseases for which ramosetron is Relevant

  1. Postoperative Nausea and Vomiting (PONV) : 42 outcomes 29 studies in 69 results
  2. Vomiting : 24 outcomes 34 studies in 74 results
  3. Nausea : 16 outcomes 26 studies in 62 results
  4. Neoplasms (Cancer) : 7 outcomes 3 studies in 18 results
  5. Diarrhea : 5 outcomes 5 studies in 26 results
Show All >>

Drugs Related to ramosetron

  1. Ondansetron (Zofran)
  2. Dexamethasone (Maxidex)
  3. Granisetron (Kytril)
  4. Cisplatin (Platino)
  5. Serotonin (5 Hydroxytryptamine)
  6. palonosetron (Aloxi)
  7. Antiemetics
  8. Propofol (Diprivan)
  9. tropisetron (Navoban)
  10. aprepitant (Emend)
Show All >>

Therapies Related to ramosetron

  1. Drug Therapy (Chemotherapy)
  2. Laparoscopic Cholecystectomy
  3. Thyroidectomy
  4. Patient-Controlled Analgesia (Analgesia, Patient Controlled)
  5. Gynecologic Surgical Procedures (Gynecologic Surgery)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.